APA (7th ed.) Citation

S, O., T, B., KM, S., H, M., C, R., LS, H., . . . RS, D. (2022). Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials. JAMA neurology, 79(11), 1113. https://doi.org/10.1001/jamaneurol.2022.2909

Chicago Style (17th ed.) Citation

S, Ostrowitzki, et al. "Evaluating the Safety and Efficacy of Crenezumab Vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials." JAMA Neurology 79, no. 11 (2022): 1113. https://doi.org/10.1001/jamaneurol.2022.2909.

MLA (9th ed.) Citation

S, Ostrowitzki, et al. "Evaluating the Safety and Efficacy of Crenezumab Vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials." JAMA Neurology, vol. 79, no. 11, 2022, p. 1113, https://doi.org/10.1001/jamaneurol.2022.2909.